What now for tax cuts after Trump s healthcare failure?

Similar documents
US: Dangerous deficits?

US import tariffs on steel and aluminium: Who stands to lose?

Romania s GDP growth rises to 7% in 2017

Taiwan: GDP riding global growth trend but prone to trade threat

Petro-currencies lose their mojo

Belgium: Just not fast enough

Key events in developed markets next week

Federal Reserve preview: A glass half full

USD: Return of the king or just a breather from a crowded short trade

What a bearish re-steepening of the Treasury curve could mean for FX

Romania: Wage growth slows

Russia: Hit by a double shot of sanctions

Key events in developed markets next week

-0.4% Japan 3Q18 GDP - blame it on the weather. Economic and Financial Analysis

The Bank of England s road to August in six charts

Dollar Regime Change: The Prequel

Three things the Fed is thinking about

2.1%, 2% Canada s yield curve: Should we be worrying? Economic and Financial Analysis

$57.2bn. Why the US trade deficit is heading the wrong way. Economic and Financial Analysis

Key events in developed markets next week

Russia-China trade in national currencies: the product mix is key

10% Asia week ahead: First test of US protectionism. Economic and Financial Analysis

Polish GDP grows by 5.1%YoY in the fourth quarter; we remain upbeat

Hungary: Consumption drives GDP growth

OPEC oil cuts: To continue or not to continue, that is the question

Brexit update: Theresa May s biggest test yet?

Four reasons why EUR/GBP won t reach parity

Central banks and rates, the definitive guide

7.50% Mexico: Another rate hike this week. Economic and Financial Analysis

US yield curve and recession risk - watch the shape not the slope

3.9% Good MornING Asia - 6 April Asia week ahead: Trade war threats weighs on central banks

Indian Banks: A fundamental overview

Key events in EMEA and Latam next week

Swiss Quarterly: On the right track

Brazil: Monetary easing reaches final stage

Is there any stopping thermal coal?

Swedish krona: A forecast revision

Crude oil: A story of demand

2,881. Metals mettle. Economic and Financial Analysis

Dollar bloc FX: Keep calm and carry off?

Shrinking oil inventories mean higher prices

What lies beneath Asian currencies pain?

Swedish Krona: Swimming naked?

Turkey Room for optimism

Trade in 2018: Nowhere close to its heyday

Swiss Economy 2018 outlook

Yapi Kredi: $1bn cap raise brings relief

Turkey central bank to remain on hold this time

Contents The best of MYR appreciation may be over A clear victory but muddled future And more economic risks ahead But some positives

Crude oil: What s in store for 2018?

How will China s new central bank governor run the new central bank?

Argentina oil & gas. Unleashing its potential. Shale development phases

Dutch Economy Chart Book

Turkey s Yapi Kredi still short of capital

Anadolu Efes returns to normal

G10 FX Week Ahead: Waiting for the ECB

Dutch Economy Chart Book

Copper: What s it going to take to flip the curve?

The end of the year marks high hopes for Brazil in 2019

Dutch Economy Chart Book

4.75% Philippines: Central bank to pause as inflation drops

NAFTA: What now for the worst trade deal ever?

Aluminium: Stakes are high for Section 232

The structural decline in the Eurozone s growth potential

Good MornING Asia - 29 June 2018

Good MornING Asia - 1 March 2018

Brazil: Dire fiscal constraints imply binary outcomes

Brexit: Seven big questions looming in 2018

EUR/CHF: Welcome back, the Swiss franc

Digital transformer. ECB policy supportive of innovation. Economic & Financial Analysis

G10 FX Week Ahead: Scusa, no can do

G10 FX Week Ahead: Dollar gets the Trump treatment

Eurozone: That late summer feeling

Brazil: Buying time with intervention

Good MornING Asia - 3 September 2018

G10 FX Week Ahead: Dollar isolationism

The dollar s inflection point

Good MornING Asia - 27 April 2018

Decision time The outlook for the UK economy, interest rates and Brexit

Good MornING Asia - 8 November 2018

Switzerland: The sun is shining but clouds loom

Indian Banks: The final cleanup

FX Market Headlines INVESTMENT PRODUCTS: NOT A BANK DEPOSIT NOT GOVERNMENT INSURED NO BANK GUARANTEE MAY LOSE VALUE. June 26 h, 2017.

Banken, krediet en eigen vermogen

2015: A rosy outlook. Vlad Muscalu Chief Economist

India: Bracing for yet another turbulent year

FX Week Ahead: Getting over the dollar rally

ECB s Sisyphean task

USD ING Memory Phoenix Autocallable ING Bank NV (NL) USD 5,000,000 Express Certificates linked to SX5E due

Strategy The big EUR curve flattening has started

Philippines 2019 GDP outlook

Our guide to central banks in 2018

FUND MANAGEMENT DIARY Meeting held on 12 September 2017

G10 FX Week Ahead: The art of trade wars

G10 FX Week Ahead: The Dollar s Hocus POTUS

Research US Further downgrade of US debt likely in 2012

Where next for global central banks?

Our view on next week s key events

MIDTERM TAKEAWAYS COMMENTARY THE BEST NEWS FIRST KEY TAKEAWAYS LPL RESEARCH WEEKLY MARKET. November

Good MornING Asia - 13 August 2018

Transcription:

Economic and Financial Analysis 19 July 2017 Global Economics 19 July 2017 Article What now for tax cuts after Trump s healthcare failure? Failure to repeal and replace Obamacare means tax cuts are likely to be delayed and diluted, putting more pressure on the USD. Contents What has happened? Healthcare reform matters for Trump s tax plans What are the challenges? What about timings? December Fed hike looks more likely US bond markets seem to have little faith in Trumpflation What has happened? Donald Trump s efforts to repeal and replace Obamacare have failed. Republican Senate majority leader Mitch McConnell found himself short of the votes needed to get it passed and instead took the decision to repeal only, but with a two-year delay. In theory, this should give Republicans enough time to come up with the healthcare replacement that has so far eluded them. This will be voted on in the coming days. Here, we look at the political knock on effects for tax, the Fed and the dollar.

Healthcare reform matters for Trump s tax plans Given Donald Trump s linking of healthcare reform with meaningful tax cuts, this development suggests that there is less scope for aggressive fiscal stimulus being approved in the near-term. At the very least it implies a dilution and delay. After all, healthcare reform was meant to save money that could help fund tax cuts. Knock-on effects for tax Source: ING What are the challenges? Healthcare and tax reform were President Trump s two big action points. Failure on the first is likely to embolden opponents while hurting the credibility of the administration, which is already seeing plunging poll ratings. Former Republican Senate majority leader Trent Lott said defeat is a blow to governing. At the very least this implies a dilution and delay to tax reform Tax reform is going to be just as divisive within the Republican Party as healthcare reform. Some Republican moderates are unhappy about tax cuts for the wealthy while cutting spending on programmes that are essential to their constituents. Meanwhile, fiscal hawks are concerned if tax cuts are not funded fully then it could lead to higher government fiscal deficits, which they will oppose. This is despite administration officials suggesting the tax cuts will be so stimulative that the additional economic output they generate will increase the taxable base, which will offset the effects of lower tax rates. Adding to the complications is the Congressional Budget Office estimate that the US will hit its debt ceiling in October, which could make fiscal hawks more obstinate. It is also important to remember that the tax bill would not qualify for a simple majority if it is expected to add to the deficit over ten years. Therefore, it would need Democrat support or the tax cuts would need to be 2

temporary. Trump will want to get fiscal policy sorted before the mid-term primaries Source: ING What about timings? Now that healthcare is not going to progress, there is the opportunity to produce a tax bill by September. There is the risk of a lengthy discussion, as with healthcare, but there appears to be a consensus that it could get approval late 2017/early 2018 assuming the challenges already mentioned can be overcome. It has to be done before the primaries ahead of the November 2018 mid-term elections. Given President Trump s low approval rating, which is unlikely to be improved by the healthcare failure, he will want to see action on tax. Otherwise, he may feel there is the real threat that Republicans might lose the majority in the House, which would severely limit his ability to pass legislation in the second half of his Presidential term. Mid-term elections: Healthcare & tax troubles could make life harder for Trump Source: Congress, ING December Fed hike looks more likely President Trump has pinned his hopes of strong growth on meaningful tax cuts so if they are going to be smaller in magnitude; then growth forecasts will be lowered. However, over recent months there has been creeping doubt over their likely timing and scale, including within the Federal Reserve. As such, it is unlikely to alter the market s outlook for the path of Fed policy given it was already extremely doubtful of the Fed s own prediction of four 25bp 3

rate hikes between now and the end of 2018. We are still forecasting three 25bp rate rises, but it makes it more likely that the next Fed rate hike will be in December rather than September. It should not necessarily impact on the timing of the Fed s balance sheet reduction programme, which could start as soon as September. US bond markets seem to have little faith in Trumpflation Markets have all but priced out any hopes of US fiscal stimulus coming through in 2017 and the narrative seems to be that this is more of a 2018 story, if anything. Of concern is the negative term premium on the US 10-year yield and lower long-term inflation expectations both suggest that we have returned to the status quo lowflation world we had been familiar with in the US economy before last year s Presidential elections. The USD is likely to remain on the back foot The USD s fall from grace has been quite spectacular, with the trade-weighted index now below pre-trump levels. As the rest of the world plays monetary catch-up, narrower interest rate differentials as well political troubles at home means that the USD is likely to remain on the back foot. Having said that, things look to have overshot in the near-term, and there is a chance that markets are currently overly pessimistic on the US and too optimistic on recovery prospects elsewhere. A bit of a normalisation in expectations could put a floor under dollar selling. Our US reflation dashboard Source: Bloomberg, ING 4

James Knightley Chief International Economist +44 20 7767 6614 james.knightley@ing.com Viraj Patel Foreign Exchange Strategist +44 20 7767 6405 viraj.patel@ing.com James Smith Developed Markets Economist +44 20 7767 1038 james.smith@ing.com 5

Disclaimer This publication has been prepared by the Economic and Financial Analysis Division of ING Bank N.V. ("ING") solely for information purposes without regard to any particular user's investment objectives, financial situation, or means. ING forms part of ING Group (being for this purpose ING Group NV and its subsidiary and affiliated companies). The information in the publication is not an investment recommendation and it is not investment, legal or tax advice or an offer or solicitation to purchase or sell any financial instrument. Reasonable care has been taken to ensure that this publication is not untrue or misleading when published, but ING does not represent that it is accurate or complete. ING does not accept any liability for any direct, indirect or consequential loss arising from any use of this publication. Unless otherwise stated, any views, forecasts, or estimates are solely those of the author(s), as of the date of the publication and are subject to change without notice. The distribution of this publication may be restricted by law or regulation in different jurisdictions and persons into whose possession this publication comes should inform themselves about, and observe, such restrictions. Copyright and database rights protection exists in this report and it may not be reproduced, distributed or published by any person for any purpose without the prior express consent of ING. All rights are reserved. The producing legal entity ING Bank N.V. is authorised by the Dutch Central Bank and supervised by the European Central Bank (ECB), the Dutch Central Bank (DNB) and the Dutch Authority for the Financial Markets (AFM). ING Bank N.V. is incorporated in the Netherlands (Trade Register no. 33031431 Amsterdam). In the United Kingdom this information is approved and/or communicated by ING Bank N.V., London Branch. ING Bank N.V., London Branch is subject to limited regulation by the Financial Conduct Authority (FCA). ING Bank N.V., London branch is registered in England (Registration number BR000341) at 8-10 Moorgate, London EC2 6DA. For US Investors: Any person wishing to discuss this report or effect transactions in any security discussed herein should contact ING Financial Markets LLC, which is a member of the NYSE, FINRA and SIPC and part of ING, and which has accepted responsibility for the distribution of this report in the United States under applicable requirements. 6